Dr. W.S. CHAN 陳慧珊博士
|
Post-doctoral Fellow Bsc; MSc (Malaysia); PhD (HKUST) |
Publications
2024
- Wang, H., Yung, M.M., Xuan, Y, Chen F., Chan W., Siu M.K.Y, Long R., Jia S., Liang Y., Xu D., Song Z., Tsui S.K.W. Ngan H.Y.S., Chan K.K.L., Chan D.W. Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment. Exp Hematol Oncol 13, 90 (2024). https://doi.org/10.1186/s40164-024-00558-8
2023
- Mo Y, Leung LL, Mak CSL, Wang X, Chan WS, Hui LMN, Tang HWM, Siu MKY, Sharma R, Xu D, Tsui SKW, Ngan HYS, Yung MMH, Chan KKL, Chan DW. Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Mol Cancer 22, 4 (2023). https://doi.org/10.1186/s12943-022-01703-9
2022
- XUAN Y., WANG H., Yung M.H., Chen F., Chan W.S., Chan Y.S., Tsui S.K.W., Ngan H.Y.S., Chan K.K.L. and Chan D.W., SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells, Theranostics. 2022, 12, 3534-3552.
2021
- Chan D.W., Lam W.Y., Chen F., Yung M.H., Chan Y.S., Chan W.S., He F., Liu S., Chan K.K.L., Li B. and Ngan H.Y.S., Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers, Clinical Epigenetics. 2021, 13. http://dx.doi.org/10.1186/s13148-021-01130-5
